Navigation Links
Sunesis Reports Financial Results for the First Quarter 2009
Date:5/6/2009

in in nonclinical studies, planned additional clinical testing and development efforts, the timing of clinical trial enrollment and the anticipated announcement of clinical results. Words such as "continued," "significant," "progress," "potential," " activity," established," "enhanced," "realize" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to Sunesis' need for additional funding, the risk that Sunesis' drug development activities could be halted significantly or delayed for various reasons, the risk that Sunesis' clinical trials for voreloxin may not demonstrate safety or efficacy or lead to regulatory approval, the risk that preliminary data and trends may not be predictive of future data or results, the risk that Sunesis' nonclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials, including the pace of enrollment, risks related to the manufacturing of voreloxin and the risk that Sunesis' proprietary rights may not adequately protect voreloxin. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Annual Report on Form 10-K/A for the year ended December 31, 2008, its quarterly report on Form 10-Q for the quarter ended March 31, 2009 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any chang
'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
4. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
8. Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 Researchers at the University ... mesothelioma and say the tried-and-true marker mesothelin is the ... article on the research. Click here to read ... Center for Asbestos Related Diseases say, even though a ... is still preferable to fibulin-3 for identifying mesothelioma. ...
(Date:6/3/2015)... According to an article published on ... fake oxycodone pills which actually contained the potent addictive ... legitimate, and even sported the “A/215” imprint common on ... 30 mg oxycodone to be exceptionally critical of their ... them illegally on the street. Fentanyl is an opiate-based ...
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis ... its grand opening with a ribbon cutting ceremony on ... of its kind in the area, Fourroux Prosthetics will ... outcomes through use of patented advanced prosthetics CAD/CAM technology. ... Fourroux Prosthetics, states, “Our goal has always been to ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 DailyEndorphin is ... "events" programming module. With this highly configurable new ... and report on many components of its wellness programming ... no additional charge. , With this new module, annual ... DE challenges, (2) Create participant surveys, (3) Continually report ...
(Date:6/3/2015)... 2015 On May 29, 2015, Health ... effective immediately, which now permits the use of gluten-free ... as ingredients. The MA is a prelude to an ... should be aware that, unlike the unlimited use of ... are restrictions for gluten-free oat products sold in Canada. ...
Breaking Medicine News(10 mins):Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3
... steadily since the 1990s; baby boomer epidemic predicted , MONDAY, ... cancer has steadily increased since the 1990s, making it by ... than all other cancers combined, two new studies find. , ... non-melanoma skin cancer in 2006, up from 1.6 million in ...
... The latest release brings many ... text to speech solution in the App Store , ... (PRWEB) March 15, 2010 -- Future Apps announces today the release of Speak it! ... The update introduces many new enhancements and user requested features that makes Speak it! the ultimate ...
... A series of free seminars scheduled for Phoenix , Reno , Salt Lake City , and Denver in May are set to help employers improve hearing ... ... ... ...
... as part of Harrington Physician Services. , ... , , ... ... Dr. Oh joins Harrington surgeons Joseph Veneziano and ...
... pap smears and early detection tests for prostate cancer, colorectal ... it becomes deadly. , However, a new study ... ethnic groups have different ideas and opinions about whether they ... influence whether they undergo screening. The study ...
... finds , MONDAY, March 15 (HealthDay News) -- Older brothers ... increased risk of developing hyperactivity, a new study finds. , ... more depression and stress than mothers without an autistic child. ... 2 to 5) diagnosed with autism and a typically developing ...
Cached Medicine News:Health News:Non-Melanoma Skin Cancers in the Millions and Rising 2Health News:Non-Melanoma Skin Cancers in the Millions and Rising 3Health News:Non-Melanoma Skin Cancers in the Millions and Rising 4Health News:Future Apps Releases Major Update to its Popular iPhone Text to Speech App Speak it 2Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 2Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 3Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 4Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 5Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 6Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 7Health News:Dr. Young-Ho Oh Joins Harrington Physician Services; Orthopedic Surgeon Will Enhance Hospital's Surgery Capabilities 2Health News:Dr. Young-Ho Oh Joins Harrington Physician Services; Orthopedic Surgeon Will Enhance Hospital's Surgery Capabilities 3Health News:Blacks have highest cancer rates of all racial ethnicities, yet feel less at risk, study finds 2Health News:Blacks have highest cancer rates of all racial ethnicities, yet feel less at risk, study finds 3Health News:Siblings of Kids With Autism May Be Prone to Hyperactivity 2
(Date:6/3/2015)... -- Varian Medical Systems (NYSE: VAR ), world leader in ... in the Middle East with the ... Arabia . Varian Medical Systems Arabia, the result of ... launched today at a ceremony attended by local dignitaries and ... move represents the next step in our commitment both to ...
(Date:6/3/2015)... South 2015 came to a successful conclusion on April 21. ... has been recognized by industry insiders through its professional and ... medical device manufacturing industry in Southern China ... successful return of the MEDTEC brand to Shenzhen ... 2005. , The most ...
(Date:6/3/2015)... 3, 2015  NxStage Medical, Inc. (Nasdaq: NXTM ... , today announced data that home hemodialysis can ... gallons of water annually by transitioning just 20 ... hemodialysis with the NxStage® System One™.  Industry data ... of water per patient per week, whereas home ...
Breaking Medicine Technology:Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually 2
... SETAUKET, N.Y., Aug. 8 Lixte,Biotechnology Holdings, Inc. ... from each of two different types of drugs ... brain cancers have,activity against human pancreatic cancers in ... President and CEO of Lixte, said, "Lixte previously,reported ...
... Bile Acid-Derived Small Molecules ... Diseases, NEW YORK, Aug. 7 Historically, ... that regulate the absorption of,dietary lipids and cholesterol ... acids have broader systemic endocrine,functions, acting as important ...
Cached Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling 2Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling 3
... manual autoclaves set the standard for steam ... to compliment any healthcare and laboratory facility. ... of your sterilization needs. Time tested reliability ... product. The Tuttnauer M Series is also ...
Subjective refraction unit, computer controlled and programmable. Two versions: with and without prisms....
... The Isoseeds I-125 are brachytherapy sources which ... of localized tumors, especially in the prostate. ... the conclusion of the therapeutic effect, i.e. ... are intended for single use. They are ...
Non-sterile oncoseed seeds consists of a welded titanium capsule containing....
Medicine Products: